The Only Technology That Detects Cracks and Failing Restorations

Introducing InnerView® AI.

InnerView solves the #1 unmet need in dentistry — detecting cracks and failing restorations using patented AI technology. 

A $14+B Total Addressable Global Market

Crack detection is one of the last untapped frontiers for AI-driven disruption, with over 800M+ potential procedures per year in the US alone.

First-Mover Advantage

The only system providing real-time crack detection, failing restoration analysis, and long-term health trendlines for every tooth - all in a single diagnostic tool.

Recurring Revenue Streams

A razor razor-blade SaaS model combining hardware sales, disposable components, and SaaS for predictable, scalable growth.

Exceptional Growth Potential

Projected to generate $275M in annual revenue by 2029.

Scientific Validation

Backed by 29 clinical studies and protected by 79 global patents.

Perhaps the best innovation since the x-ray.”

Robert Kelly, DDS., PhD.

Prosthodontic Researcher and professor, Reconstructive Sciences, University of Connecticut

I have been waiting for this technology ever since I graduated from dental school 35 years ago!

Cynthia Brattesani, DDS

InnerView gives us a snapshot of the internal structural integrity of a tooth that may not be identified clinically or radiographically."

Dr. Bao-Thy Grant, DDS

Board-Certified Oral & Maxillofacial Surgeon

InnerView: The New Standard in Diagnostics

InnerView is reshaping the future of dental diagnostics, providing an advanced, data-driven solution for a field long overdue for innovation. With a scalable business model and unmatched clinical validation, InnerView is positioned to revolutionize dental care globally.

Unparalleled Market Potential

A $14B+ untapped global market with over 800M+ potential annual procedures in the US alone.

Razor Razor-Blade SaaS Model

Hardware sales, disposable components, and SaaS revenues, ensure consistent, predictable growth.

Projected Growth

Forecasted to reach $275M in annual revenue by 2029.

This website contains information about prospective technologies currently under development and clinical evaluation. Certain diagnostic claims, such as AI/ML crack detection, refer to investigational devices that have not yet received FDA clearance.